Tan, Zhiyuan
Völler, Swantje
Yin, Anyue
Rieborn, Amy
Gelderblom, A. J.
van der Hulle, Tom
Knibbe, Catherijne A. J.
Moes, Dirk Jan A. R. http://orcid.org/0000-0003-3219-253X
Article History
Accepted: 18 April 2024
First Online: 14 June 2024
Declarations
:
: The work of Zhiyuan Tan was supported by the China Scholarship Council (202108310028).
: No disclosures are applicable for this work. None of the other authors have any conflicts to declare.
: This study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol was approved by the Institutional Review Board (IRB) at the Scientific Committee of the Department of Medical Oncology, Medical Ethics Review Committee Leiden/Den Haag/Delft. As retrospective data from routine clinical care were used, a waiver was granted for the requirement of informed consent by the IRB.
: This study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol was approved by the Institution Review Board (IRB) at Scientific Committee of Clinical Oncology, Medical Ethics Review Committee Leiden/Den Haag/Delft. As data from routine care were used, a waiver was granted for the requirement of informed consent by IRB.
: This study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol was approved by the Institution Review Board (IRB) at Scientific Committee of Clinical Oncology, Medical Ethics Review Committee Leiden/Den Haag/Delft. As data from routine care were used, a waiver was granted for the requirement of informed consent by IRB.
: Data are available from the corresponding author upon reasonable request.
: NONMEM codes are available in the supplements.
: ZT, SV, AY, CAJK and DJARM contributed to the research design, performed research, analyzed data, and wrote the manuscript and AR, AJG, TH treated patients and reviewed and revised the manuscript.